In India, questions over decision to treat rape victim overseas

Women carrying placards enter Raj Ghat to attend a prayer ceremony for a rape victim after a rally protesting for justice and security for women, in New DelhiNEW DELHI (Reuters) – The decision to fly the victim of a gang rape that outraged India for treatment in Singapore made little medical sense as the woman was so severely injured that her death was all but inevitable, doctors say. The government, on the back foot after furious street protests and stinging criticism of authorities over the December 16 rape in the capital, New Delhi, has struggled to defend its decision to send the 23-year-old physiotherapy student overseas. She died 48 hours later. …

Trafficked maids to order: The darker side of richer India

NEW DELHI, Dec 4 (TrustLaw) – Inside the crumbling housing estates of Shivaji Enclave, amid the boys playing cricket and housewives chatting from their balconies, winding staircases lead to places where lies a darker side to India’s economic boom. Three months ago, police rescued Theresa Kerketa from one of these tiny two-roomed flats. For four years, she was kept here by a placement agency for domestic maids, in between stints as a virtual slave to Delhi’s middle-class homes. …

GSK to spend $1 billion to lift stakes in India, Nigeria units

A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company resultsMUMBAI (Reuters) – GlaxoSmithKline Plc plans to spend more than $1 billion to raise stakes in its Indian and Nigerian consumer healthcare arms, as Britain's biggest drugmaker deepens its emerging markets and non-prescription consumer health footprint. The deals are the latest of several by GSK, which is reducing its reliance on traditional prescription drug markets in Western economies where sales are slowing. GSK said on Monday it will buy up to an additional 31.8 percent stake in India's GlaxoSmithKline Consumer Healthcare Ltd for about $940 million by paying 3,900 rupees ($70. …

India government approves new drug pricing policy

NEW DELHI (Reuters) – The Indian government approved on Thursday a new drug pricing policy, two ministers told reporters, a move that will regulate the prices of 348 drugs deemed essential. India’s domestic drug market, the fourth largest in the world by volume, is valued at nearly $13 billion. (Reporting by Nigam Prusty; editing by Rajesh Kumar Singh)

Exclusive: Abbott suspends giving gifts to doctors in India

A representative for Abbott rides his bike to a doctor's clinic in PuneNEW YORK (Reuters Health) – Abbott Laboratories Inc has instructed its sales representatives in India not to give gifts to doctors, who are prohibited by local law from accepting them, a practice that has been used as a bargaining chip by companies wanting a piece of the country's burgeoning healthcare market. According to an internal email dated October 11 from Sudarshan Jain, managing director of Abbott Healthcare Pvt. Ltd, the gift-giving has been temporarily suspended. …

Americans’ heart devices reused safely in India

NEW YORK (Reuters Health) – U.S. patients’ used heart devices can be safely implanted in seriously ill heart disease patients in the developing world, a study out Monday suggests. “These devices did work well. They delivered appropriate shocks and saved lives,” said lead researcher Dr. Behzad B. Pavri, of Thomas Jefferson University Hospital in Philadelphia. The devices, known as implantable cardioverter defibrillators (ICDs), automatically deliver potentially life-saving electrical shocks to the heart in people at high risk of cardiac arrest. …

1 2 3 10